Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2003
10/08/2003EP1350844A2 Xyloglucanase, polynucleotide encoding the enzyme, and method of preparing the enzyme
10/08/2003EP1350838A1 Expression of recombinant human proteins in Tetrahymena
10/08/2003EP1350799A2 Inhibitory Immunoglobulin Polypeptides to Human PDGF Beta Receptor
10/08/2003EP1350105A2 Immunoassays for anti-hcv antibodies
10/08/2003EP1350101A2 Morphometric tissue or cell preparation
10/08/2003EP1350085A2 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc)
10/08/2003EP1349955A2 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia
10/08/2003EP1349947A2 Processes and vectors for plastid transformation
10/08/2003EP1349946A2 Plant polynucleotides encoding prenyl proteases
10/08/2003EP1349944A2 Latency associated peptide for providing latency to pharmaceutically active proteins
10/08/2003EP1349940A2 55562 and 21617, novel human proteins and methods of use thereof
10/08/2003EP1349939A2 Aminoacyl trna synthetases
10/08/2003EP1349936A2 Regulation of human b7-h2 protein
10/08/2003EP1349931A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/08/2003EP1349930A2 Human proteins, polynucleotides encoding them and methods of using the same
10/08/2003EP1349928A2 A novel human g-protein coupled reciptor hgprbmy11 expressed highly in heart and variants thereof
10/08/2003EP1349926A2 Complementing cell lines
10/08/2003EP1349924A2 Methods and compositions for the diagnosis of cancer susceptibilites and defective dna repair mechanisms and treatment thereof
10/08/2003EP1349920A2 Adenylate cyclases
10/08/2003EP1349919A1 Extramedullary adipose tissue cells and use thereof for regenerating hematopoietic and muscular tissues
10/08/2003EP1349918A1 Method of collecting placental stem cells
10/08/2003EP1349917A1 Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
10/08/2003EP1349873A2 Modulation of il-2- and il-15-mediated t cell responses
10/08/2003EP1349870A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
10/08/2003EP1349582A2 Substrates containing polyphosphazene as matrixs and substrates containing polyphosphazene with a microstructured surface
10/08/2003EP1349569A2 Intrinsically fluorescent, self-multimerizing mhc fusion proteins and complexes thereof
10/08/2003EP1349565A2 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules
10/08/2003EP1349485A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
10/08/2003EP1100530B1 In-vitro stimulation of beta cell proliferation
10/08/2003EP1045918A4 G protein-related kinase mutants in essential hypertension
10/08/2003EP0882130B1 Human cancer antigen of tyrosinase-related protein 1 and gene encoding same
10/08/2003EP0865448B1 Apoptosis induced by monoclonal antibody anti-her2
10/08/2003EP0743948B2 Separation of nucleic acids by chromatography
10/08/2003EP0670898B1 Interleukin-3 (il-3) mutant polypeptides
10/08/2003EP0566647B1 Improved humanized immunoglobulins
10/08/2003CN1447920A Compsns. and methods for modulating tumor specific expression
10/08/2003CN1447857A Agonist anti-TRK-C monoclonal antibodies
10/08/2003CN1447856A Nucleic acid sequences and methods for modification of plant gene expression
10/08/2003CN1447854A Monkey-origin embryonic stem cells
10/08/2003CN1447819A Human CYR 61
10/08/2003CN1446907A Method for proliferating and differentiating nerve stem cells under medication inducement and its application
10/08/2003CN1446583A Composition, preparation and application scheme of tumor immunological therapy and preventative vaccine
10/08/2003CN1123574C Ligands for FLT3 receptors
10/08/2003CN1123360C Inhibitors of cyclophilin rotamase activity
10/08/2003CA2424683A1 Hla matching donor-originating activated lymphocytes to be used in prevention/treatment of tumors, infectious diseases and autoimmune diseases, treatment method achieved by using the lymphocytes, formula having the lymphocytes as a main constituent thereof, method for manufacturing the formula and preparation kit to be used to prepare the formula
10/07/2003USH2085 High molecular weight polypeptides used to screen for enzyme inhibitors, such as transferases, hydrolases or proteolytic enzymes; antibiotic resistance
10/07/2003US6630619 Insecticides; insecticidal proteins; genetic engineering; nematodes; symbionic bacteria; use of isolated polynucleotide encoding insecticidal protein to transform insect-specific viruses, bacteria, yeasts and plants to control insect pests
10/07/2003US6630616 Arabidopsis MPC1 gene and methods for controlling flowering time
10/07/2003US6630574 Compositions and methods for the therapy and diagnosis of lung cancer
10/07/2003US6630480 Methods of treating leukemia
10/07/2003US6630466 Anticholinergics which have a long-lasting effect, such as glycopyrronium bromide, tiotropium bromide or an ester of bi-or tricyclic amino alcohol such as a nortropanol
10/07/2003US6630459 Immunoisolation of a cell; use of biomedically pure, p-GlcNAc of high molecular weight and consistent properties.
10/07/2003US6630457 Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
10/07/2003US6630450 Method of treating dyslipidemia
10/07/2003US6630448 Isolated endostatin, especially approximately 20 kDa and corresponds to a C-terminal fragment of collagen type XVIII
10/07/2003US6630350 Monoclonal antibodies against a human act and serine protease complex
10/07/2003US6630349 Trophoblast cell preparations
10/07/2003US6630347 Endothelial NOS transgenic animals and methods of use
10/07/2003US6630344 Adenoviral vectors; use for gene therapy, vaccines and for the transformation of cells
10/07/2003US6630343 Hepatitis C virus culture system
10/07/2003US6630341 Phosphohexuloisomerase and gene therefor
10/07/2003US6630337 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/07/2003US6630331 Isolated DNA encoding a protein from Lotus japonicus which has pantothenate synthetase activity; enzyme inhibitors
10/07/2003US6630322 Adenovirus comprising DNA with a origin of replication of epstein-barr virus, promoter, nucleotide sequence encoding a protein and internal ribosome entry site sequence of an encephalomyocarditis virus; site-specific recombination
10/07/2003US6630314 Noninvasive detection of colorectal cancer and other gastrointestinal pathology
10/07/2003US6630313 Phosphatidyl serine receptors and uses thereof
10/07/2003US6630304 Human osteoporosis gene
10/07/2003US6630298 HCV antigen/antibody combination assay
10/07/2003US6630297 Methods of screening for agents that modulate the interaction of human ECT2 polypeptide with an ECT2 binding target
10/07/2003US6630148 Amino acid sequence binds to naturally occurring patched receptor; generate and/or maintain an array of vertebrate tissue; expression of secondary signaling molecules, such as Transforming Growth Factors and fibroblast growth factors
10/07/2003US6630144 Monoclonal antibodies to Ebola glycoprotein
10/07/2003US6630143 Monoclonal antibodes, treating hematopoietic disorders, in particular, aplastic anemia and myelodysplastic syndromes
10/07/2003US6630138 Protein C derivatives
10/07/2003CA2321781C Particle bombardment transformation of brassica
10/07/2003CA2280290C Netrin receptors
10/07/2003CA2211204C Prostaglandin receptor dp
10/07/2003CA2207286C Localized delivery of factors enhancing survival of transplanted cells
10/07/2003CA2132540C A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses
10/07/2003CA1341443C Human c3b/c4b receptor (cr1) (the)
10/07/2003CA1341442C Transgenic animals
10/02/2003WO2003081251A1 Novel compositions and methods in cancer associated with altered expression of prdm 11
10/02/2003WO2003081250A1 Novel compositions and methods in cancer associated with altered expression of prlr
10/02/2003WO2003081249A2 Method for the detection of prion proteins
10/02/2003WO2003081237A1 Detection and isolation of cell populations from muscle using antibodies to fa1/dlk1
10/02/2003WO2003080856A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/02/2003WO2003080853A1 Novel compositions and methods in cancer associated with altered expression of tbx21
10/02/2003WO2003080842A1 Zearalenone-detoxifying enzyme gene and transformant having the gene transferred thereinto
10/02/2003WO2003080836A1 Nerve regeneration genes
10/02/2003WO2003080835A1 Erbb3 based methods and compositions for treating neoplasms
10/02/2003WO2003080833A1 Xanthosine methylase and use thereof
10/02/2003WO2003080824A1 Hapatitis b viral packaging system
10/02/2003WO2003080822A1 Placenta-origin mesenchymal cells and medicinal use thereof
10/02/2003WO2003080821A1 Method of proliferating human hepatocytes and method of obtaining human hepatocytes
10/02/2003WO2003080820A2 Mammalian permanent growth factor-independent cell line and method of its production
10/02/2003WO2003080819A1 Process for effluxing betalaines from beta vulgaris hairy root cultures
10/02/2003WO2003080818A1 Method of inducing growth of nerve stem cells
10/02/2003WO2003080817A1 Process for producing cytotoxic lymphocyte
10/02/2003WO2003080816A2 Stem cell culture
10/02/2003WO2003080815A2 Method for activating dendritic cells
10/02/2003WO2003080808A2 Novel compositions and methods in cancer